Page 1

20 - F 1 brhc10022119_20f.htm 20 - F ( Mark One ) ☐ ☐ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington , D.C. 20549 FORM 20 - F REGISTRATION STATEMENT PURSUANT TO SECTION 12 ( b ) OR ( g ) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF П 1934 For the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report Commission file number : 001-38283 InflaRx N.V. ( Exact name of Registrant as specified in its charter ) The Netherlands ( Jurisdiction of incorporation or organization ) Winzerlaer Str . 2 07745 Jena , Germany ( +49 ) 3641 508 180 ( Address of principal executive offices ) Dr. Thomas Taapken , Chief Financial Officer Tel : ( +49 ) 89 4141 897 800 Fraunhoferstr . 22 , 82152 Planegg - Martinsried , Germany ( Name , Telephone , E - mail and / or Facsimile number and Address of Company Contact Person ) Copies to : Sophia Hudson Kirkland & Ellis LLP 601 Lexington Avenue New York , NY 10022 Phone : ( 212 ) 446-4750 Securities registered or to be registered pursuant to Section 12 ( b ) of the Act : Title of each class Common Shares , nominal value € 0.12 per share Trading Symbol ( s ) IFRX Name of each exchange on which registered The NASDAQ Stock Market LLC